309 related articles for article (PubMed ID: 6805532)
21. DDAVP in haemophilia and von Willebrand's disease.
Lancet; 1983 Oct; 2(8353):774-5. PubMed ID: 6137606
[No Abstract] [Full Text] [Related]
22. Effectiveness of D-arginine vasopressin in von Willebrand's disease.
Bala L; Boggio L; Green D
Curr Hematol Rep; 2005 Jan; 4(1):1-2. PubMed ID: 15610653
[No Abstract] [Full Text] [Related]
23. IIB von Willebrand's disease: pathogenetic and therapeutic studies.
Kyrle PA; Niessner H; Dent J; Panzer S; Brenner B; Zimmerman TS; Lechner K
Br J Haematol; 1988 May; 69(1):55-9. PubMed ID: 3132965
[TBL] [Abstract][Full Text] [Related]
24. DDAVP in von Willebrand's disease: repeated administration and the behaviour of the bleeding time.
Theiss W; Schmidt G
Thromb Res; 1978 Dec; 13(6):1119-23. PubMed ID: 311959
[No Abstract] [Full Text] [Related]
25. The effect of DDAVP on plasma levels of von Willebrand antigen II in normal individuals and patients with von Willebrand's disease.
McCarroll DR; Ruggeri ZM; Montgomery RR
Blood; 1984 Mar; 63(3):532-5. PubMed ID: 6607754
[TBL] [Abstract][Full Text] [Related]
26. DDAVP-induced changes of factor VIII-related activities and bleeding time in patients with von Willebrand's syndrome.
Schmitz-Huebner U; Balleisen L; Arends P; Pollmann H; Sutor AH
Haemostasis; 1980; 9(4):204-13. PubMed ID: 6772527
[TBL] [Abstract][Full Text] [Related]
27. [Hemostatic effect of deamino-8-D-arginine vasopressin (DDAVP) in hemophilia A and von Willebrand's disease].
Fukui H; Takase T
Rinsho Ketsueki; 1985 Jul; 26(7):1069-79. PubMed ID: 3932720
[No Abstract] [Full Text] [Related]
28. Acquired von Willebrand's disease in the myeloproliferative syndrome.
Budde U; Schaefer G; Mueller N; Egli H; Dent J; Ruggeri Z; Zimmerman T
Blood; 1984 Nov; 64(5):981-5. PubMed ID: 6333259
[TBL] [Abstract][Full Text] [Related]
29. Hyper-responsiveness to DDAVP for patients with type I von Willebrand's disease and normal intra-platelet von Willebrand factor.
Rodeghiero F; Castaman G; Di Bona E; Ruggeri M; Lombardi R; Mannucci PM
Eur J Haematol; 1988 Feb; 40(2):163-7. PubMed ID: 3126081
[TBL] [Abstract][Full Text] [Related]
30. The role of the spleen in regulating the plasma levels of factor VIII--von Willebrand's factor after DDAVP.
Garcia VV; Coppola R; Mannucci PM
Blood; 1982 Dec; 60(6):1402-6. PubMed ID: 6814552
[TBL] [Abstract][Full Text] [Related]
31. [Multimeric composition of factor VIII-related protein following DDAVP infusion in normal subjects and patients with hemophilia A and von Willebrand's disease].
Takase T; Nishino M; Yasui M; Shima M; Yoshikawa N; Fukui H
Nihon Ketsueki Gakkai Zasshi; 1985 Nov; 48(7):1571-8. PubMed ID: 3937410
[No Abstract] [Full Text] [Related]
32. The heterogeneity of type IIA von Willebrand's disease: studies with protease inhibitors.
Batlle J; Lopez Fernandez MF; Campos M; Justica B; Berges C; Navarro JL; Diaz Cremades JM; Kasper CK; Dent JA; Ruggeri ZM
Blood; 1986 Dec; 68(6):1207-12. PubMed ID: 3490883
[TBL] [Abstract][Full Text] [Related]
33. Effect of desmopressin acetate on bleeding times and plasma von Willebrand factor in Doberman pinscher dogs with von Willebrand's disease.
Kraus KH; Turrentine MA; Jergens AE; Johnson GS
Vet Surg; 1989; 18(2):103-9. PubMed ID: 2786279
[TBL] [Abstract][Full Text] [Related]
34. [Willebrand's disease and multimeric analysis of the Willebrand factor].
Hauert J; Tran-Thang C; Bachmann F
Schweiz Med Wochenschr; 1985 Dec; 115(49):1773-5. PubMed ID: 3879003
[TBL] [Abstract][Full Text] [Related]
35. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.
Casonato A; Pontara E; Dannhäuser D; Bertomoro A; Sartori MT; Girolami A
Haematologia (Budap); 1994; 26(2):97-109. PubMed ID: 7890268
[TBL] [Abstract][Full Text] [Related]
36. [Response to DDAVP in von Willebrand disease type II C].
Batllé Fonrodona J; López Fernández MF; Martín González R; Fernández Villamor A; López Borrasca A; Lasierra Cirujeda J
Sangre (Barc); 1985; 30(2):181-4. PubMed ID: 3925573
[No Abstract] [Full Text] [Related]
37. Evaluation of the effectiveness of DDAVP in surgery and in bleeding episodes in haemophilia and von Willebrand's disease. A study on 43 patients.
Mariana G; Ciavarella N; Mazzucconi MG; Antoncecchi S; Solinas S; Ranieri P; Pettini P; Agrestini F; Mandelli F
Clin Lab Haematol; 1984; 6(3):229-38. PubMed ID: 6440729
[TBL] [Abstract][Full Text] [Related]
38. Discrepant increase in factor VIII: C and von Willebrand factor after DDAVP infusion in a patient with variant von Willebrand's disease.
Casonato A; Sartori MT; Pontara E; Bertomoro A; Dannhäuser D; Girolami
Blood Coagul Fibrinolysis; 1991 Aug; 2(4):567-73. PubMed ID: 1768767
[TBL] [Abstract][Full Text] [Related]
39. Response of patients with hemophilia A and von Willebrand disease to desmopressin (DDAVP).
Santiago-Borrero PJ; Casanova R
Bol Asoc Med P R; 1990 May; 82(5):207-10. PubMed ID: 2115785
[TBL] [Abstract][Full Text] [Related]
40. Aberrant multimeric structure of von Willebrand factor in a new variant of von Willebrand's disease (type IIC).
Ruggeri ZM; Nilsson IM; Lombardi R; Holmberg L; Zimmerman TS
J Clin Invest; 1982 Nov; 70(5):1124-7. PubMed ID: 6982283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
